Back to search
FDAFDA · Food and drugs·Recall number D-0699-2021

Chantix (varenicline) tablets, 0.5mg*, 56 Tablets, Rx Only, Distributed by Pfizer Labs, Division of Pfizer Inc., NY, NY 10017, Made in Ireland. NDC 0069-0468-56

Published August 11, 2021 · Recall initiated: June 9, 2021

Summary

FDA records drug Class II recall D-0699-2021, published August 11, 2021 and initiated June 9, 2021. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 59,232 bottles; Lot: Lots 00019213, Exp 31 Jan 2022 & EC6994, Exp May 31, 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

What to do

Voluntary: Firm initiated · Letter

Get an email if CHANTIX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHANTIX
Manufacturer
Pfizer Inc.
Distributor
Nationwide
UPC
0300690469560
Lot
Lots 00019213, Exp 31 Jan 2022 & EC6994, Exp May 31, 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Chantix (varenicline) tablets, 0.5mg*, 56 Tablets, Rx Only, Distributed by Pfizer Labs, Division of Pfizer Inc., NY, NY 10017, Made in Ireland. NDC 0069-0468-56 recalled?

Yes. FDA published recall D-0699-2021 on August 11, 2021. Reported hazard: CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHANTIX. UPC: 0300690469560.